Measles Humoral and Cell-Mediated Immunity in Children Aged 5–10 Years After Primary Measles Immunization Administered at 6 or 9 Months of Age

Background. Given the high infant measles mortality rate, there is interest in whether a measles immunization regimen beginning at <12 months of age provides lasting immunity. Methods. Measles-specific immune responses were evaluated in 70 children aged 5–10 years after primary measles vaccine ad...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gans, Hayley A., Yasukawa, Linda L., Sung, Phillip, Sullivan, Barbara, DeHovitz, Ross, Audet, Susette, Beeler, Judy, Arvin, Ann M.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2013
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3549597/
https://ncbi.nlm.nih.gov/pubmed/23300162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis719
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars